Live Breaking News & Updates on Teva Pharmaceutical Industries Company Profile

Stay updated with breaking news from Teva pharmaceutical industries company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jump Financial LLC Lowers Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Jump Financial LLC reduced its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 16.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 218,799 shares of the company’s stock after selling 42,321 shares during the quarter. Jump Financial LLC’s holdings in Teva […] ....

United States , Piper Sandler , Jump Financial , Exchange Commission , News Ratings For Teva Pharmaceutical Industries Daily , Teva Pharmaceutical Industries Trading , Money Concepts Capital Corp , Quilter Plc , Jefferies Financial Group , Quarter For Teva Pharmaceutical Industries , Teva Pharmaceutical Industries Limited , Teva Pharmaceutical Industries , Teva Pharmaceutical Industries Company Profile , Free Report , Concepts Capital Corp , Spire Wealth Management , Wealth Management , Financial Group , Pharmaceutical Industries Limited , Pharmaceutical Industries , Get Free Report , North America , Teva Pharmaceutical Industries Daily , Nyse Teva , Sec Filings , Hedge Fund Holdings ,

Teva Pharmaceutical Industries (NYSE:TEVA) Updates FY24 Earnings Guidance

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $2.20-$2.50 for the period, compared to the consensus EPS estimate of $2.41. The company issued revenue guidance of $15.7-$16.3 billion, compared to the consensus revenue estimate of $15.57 billion. Teva Pharmaceutical Industries also updated […] ....

United States , Piper Sandler , News Ratings For Teva Pharmaceutical Industries Daily , Jefferies Financial Group , Teva Pharmaceutical Industries Stock Performance , Unisuper Management Pty Ltd , Tower Research Capital , Snowden Capital Advisors , Teva Pharmaceutical Industries Company Profile , Money Concepts Capital Corp , Teva Pharmaceutical Industries , Get Free Report , Pharmaceutical Industries , Financial Group , Moderate Buy , Concepts Capital Corp , Research Capital , Super Management Pty Ltd , Pharmaceutical Industries Limited , North America , Teva Pharmaceutical Industries Daily , Nyse Teva ,

Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 1-Year High at $12.04

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $12.04 and last traded at $11.99, with a volume of 5148017 shares changing hands. The stock had previously closed at $11.49. Wall Street Analyst Weigh In A […] ....

United States , Piper Sandler , Jefferies Financial Group , Teva Pharmaceutical Industries Limited , Blackrock Inc , Great West Life Assurance Co , News Ratings For Teva Pharmaceutical Industries Daily , Teva Pharmaceutical Industries , Teva Pharmaceutical Industries Price Performance , Metlife Investment Management , York Mellon Corp , Financial Services Group Inc , Teva Pharmaceutical Industries Company Profile , Get Free Report , Pharmaceutical Industries , New York Mellon Corp , Services Group , Life Investment Management , Great West Life Assurance , West Life Assurance , Pharmaceutical Industries Limited , North America , Teva Pharmaceutical Industries Daily , Nyse Teva ,

Teva Pharmaceutical Industries (NYSE:TEVA) Receives New Coverage from Analysts at HSBC

HSBC began coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) in a research note issued to investors on Monday morning, Marketbeat reports. The firm issued a buy rating and a $13.00 target price on the stock. Other analysts also recently issued research reports about the company. Bank of America lifted their price […] ....

United States , Teva Pharmaceutical Industries , Lingotto Investment Management , Analyst Recommendations For Teva Pharmaceutical Industries , Teva Pharmaceutical Industries Company Profile , Teva Pharmaceutical Industries Stock Performance , Harel Insurance Investments Financial Services Ltd , Clal Insurance Enterprises Holdings Ltd , Shore Management Inc , News Ratings For Teva Pharmaceutical Industries Daily , Free Report , Moderate Buy , Pharmaceutical Industries , Get Free Report , Insurance Investments , Financial Services , Capital Management , Insurance Enterprises Holdings Ltd , Investment Management , Pharmaceutical Industries Limited , North America , Teva Pharmaceutical Industries Daily , Nyse Teva , Initiated Coverage , Hsbc Holdings Plc ,

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Rating of "Moderate Buy" from Analysts

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Capital Fund Management , Affinity Asset Advisors , Teva Pharmaceutical Industries Limited , News Ratings For Teva Pharmaceutical Industries Daily , Nomura Asset Management Co , Teva Pharmaceutical Industries Stock Performance , Teva Pharmaceutical Industries , Teva Pharmaceutical Industries Company Profile , Analyst Recommendations For Teva Pharmaceutical Industries , Get Free Report , Capital Management , Asset Advisors , Kantonalbank Zurich Cantonalbank , Nomura Asset Management , Asset Management , Pharmaceutical Industries , Get Free , Pharmaceutical Industries Limited , North America , Teva Pharmaceutical Industries Daily , Nyse Teva ,